Downloadable Slideset

Share

Program Content

Activities

  • SGLT2i Across EF
    The New Standard of Care: Leveraging the Benefits of SGLT2 Inhibitors Across the Heart Failure Spectrum
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 04, 2023

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company